Mind the Animals: Call for Regulation of Wildlife to Prevent COVID ‘Reservoirs’ 08/03/2022 Aishwarya Tendolkar Countries need to prevent more SARS-CoV2 infections in wildlife, as this could result in the establishment of animal reservoirs, according to a joint statement by the World Health Organisation, Food and Agriculture Organisation (FAO), and the World Organisation for Animal Health (OIE). So far domestic animals, free-ranging, captive or farmed wild animals such as big […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> New Studies Contend: Wuhan Market Animals, Not Laboratory, First Infected Humans with SARS-COV2 28/02/2022 Kerry Cullinan Three pre-print papers published over the past few days have strengthened the case for the theory that SARS-COV2 first spread among people via infected animals sold and slaughtered at the Huanan wildlife market in Wuhan – rather than from the Wuhan Institute of Virology, the laboratory studying coronaviruses in bats. The two theories have been […] Continue reading -> Expanding Global Research Capabilities to Prepare for Future Pandemics 27/02/2022 Raisa Santos From increasing disease surveillance and developing a pan-coronavirus vaccine to ‘eco-health’ and public trust, participants in the COVID-19 Global Research and Innovation Forum considered ways to globally prepare for future pandemics and end the current one. The third such forum, hosted by the World Health Organization, brought together over 100 research scientists, experts, policy makers, […] Continue reading -> Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> One COVID Vaccine Jab After Recovery Cut Risk of Reinfection by Delta Variant Up to 82% 18/02/2022 Maayan Hoffman Individuals who recovered from COVID-19 and then received at least one shot of the Pfizer mRNA COVID-19 vaccine had a significantly lower risk of reinfection, according to a new study published Wednesday’s New England Journal of Medicine,. The study was conducted by researchers at Israel’s Clalit Health Services, in collaboration with Ben-Gurion University and Sapir […] Continue reading -> BA.2 Now Dominant in South Africa: Could New ‘Stealth’ Sub-Variant Delay Hoped-For Pandemic Reprieve? 11/02/2022 Maayan Hoffman The BA.2 sub-variant of Omicron is now the dominant COVID-19 variant in South Africa, the head of Africa’s Centers for Disease Control and Prevention (CDC) confirmed on Thursday – raising questions about whether the continued global creep of the new SARS-CoV2 sub-variant could dash hopes of a much-needed COVID-19 reprieve. “We have data from South […] Continue reading -> New Study Shows Correlation Between Vitamin D Deficiency and Severe COVID 07/02/2022 Maayan Hoffman Researchers make the argument for increasing vitamin D supplementation in low- and middle-income countries, where vaccines and other methods of COVID prevention may be less available. Maintaining adequate vitamin D levels could play a critical role in protecting against serious illness or death from COVID-19, according to new Israeli research. The study, published last week […] Continue reading -> In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> Posts navigation Older postsNewer posts
WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> New Studies Contend: Wuhan Market Animals, Not Laboratory, First Infected Humans with SARS-COV2 28/02/2022 Kerry Cullinan Three pre-print papers published over the past few days have strengthened the case for the theory that SARS-COV2 first spread among people via infected animals sold and slaughtered at the Huanan wildlife market in Wuhan – rather than from the Wuhan Institute of Virology, the laboratory studying coronaviruses in bats. The two theories have been […] Continue reading -> Expanding Global Research Capabilities to Prepare for Future Pandemics 27/02/2022 Raisa Santos From increasing disease surveillance and developing a pan-coronavirus vaccine to ‘eco-health’ and public trust, participants in the COVID-19 Global Research and Innovation Forum considered ways to globally prepare for future pandemics and end the current one. The third such forum, hosted by the World Health Organization, brought together over 100 research scientists, experts, policy makers, […] Continue reading -> Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> One COVID Vaccine Jab After Recovery Cut Risk of Reinfection by Delta Variant Up to 82% 18/02/2022 Maayan Hoffman Individuals who recovered from COVID-19 and then received at least one shot of the Pfizer mRNA COVID-19 vaccine had a significantly lower risk of reinfection, according to a new study published Wednesday’s New England Journal of Medicine,. The study was conducted by researchers at Israel’s Clalit Health Services, in collaboration with Ben-Gurion University and Sapir […] Continue reading -> BA.2 Now Dominant in South Africa: Could New ‘Stealth’ Sub-Variant Delay Hoped-For Pandemic Reprieve? 11/02/2022 Maayan Hoffman The BA.2 sub-variant of Omicron is now the dominant COVID-19 variant in South Africa, the head of Africa’s Centers for Disease Control and Prevention (CDC) confirmed on Thursday – raising questions about whether the continued global creep of the new SARS-CoV2 sub-variant could dash hopes of a much-needed COVID-19 reprieve. “We have data from South […] Continue reading -> New Study Shows Correlation Between Vitamin D Deficiency and Severe COVID 07/02/2022 Maayan Hoffman Researchers make the argument for increasing vitamin D supplementation in low- and middle-income countries, where vaccines and other methods of COVID prevention may be less available. Maintaining adequate vitamin D levels could play a critical role in protecting against serious illness or death from COVID-19, according to new Israeli research. The study, published last week […] Continue reading -> In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> Posts navigation Older postsNewer posts
Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> New Studies Contend: Wuhan Market Animals, Not Laboratory, First Infected Humans with SARS-COV2 28/02/2022 Kerry Cullinan Three pre-print papers published over the past few days have strengthened the case for the theory that SARS-COV2 first spread among people via infected animals sold and slaughtered at the Huanan wildlife market in Wuhan – rather than from the Wuhan Institute of Virology, the laboratory studying coronaviruses in bats. The two theories have been […] Continue reading -> Expanding Global Research Capabilities to Prepare for Future Pandemics 27/02/2022 Raisa Santos From increasing disease surveillance and developing a pan-coronavirus vaccine to ‘eco-health’ and public trust, participants in the COVID-19 Global Research and Innovation Forum considered ways to globally prepare for future pandemics and end the current one. The third such forum, hosted by the World Health Organization, brought together over 100 research scientists, experts, policy makers, […] Continue reading -> Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> One COVID Vaccine Jab After Recovery Cut Risk of Reinfection by Delta Variant Up to 82% 18/02/2022 Maayan Hoffman Individuals who recovered from COVID-19 and then received at least one shot of the Pfizer mRNA COVID-19 vaccine had a significantly lower risk of reinfection, according to a new study published Wednesday’s New England Journal of Medicine,. The study was conducted by researchers at Israel’s Clalit Health Services, in collaboration with Ben-Gurion University and Sapir […] Continue reading -> BA.2 Now Dominant in South Africa: Could New ‘Stealth’ Sub-Variant Delay Hoped-For Pandemic Reprieve? 11/02/2022 Maayan Hoffman The BA.2 sub-variant of Omicron is now the dominant COVID-19 variant in South Africa, the head of Africa’s Centers for Disease Control and Prevention (CDC) confirmed on Thursday – raising questions about whether the continued global creep of the new SARS-CoV2 sub-variant could dash hopes of a much-needed COVID-19 reprieve. “We have data from South […] Continue reading -> New Study Shows Correlation Between Vitamin D Deficiency and Severe COVID 07/02/2022 Maayan Hoffman Researchers make the argument for increasing vitamin D supplementation in low- and middle-income countries, where vaccines and other methods of COVID prevention may be less available. Maintaining adequate vitamin D levels could play a critical role in protecting against serious illness or death from COVID-19, according to new Israeli research. The study, published last week […] Continue reading -> In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> Posts navigation Older postsNewer posts
New Studies Contend: Wuhan Market Animals, Not Laboratory, First Infected Humans with SARS-COV2 28/02/2022 Kerry Cullinan Three pre-print papers published over the past few days have strengthened the case for the theory that SARS-COV2 first spread among people via infected animals sold and slaughtered at the Huanan wildlife market in Wuhan – rather than from the Wuhan Institute of Virology, the laboratory studying coronaviruses in bats. The two theories have been […] Continue reading -> Expanding Global Research Capabilities to Prepare for Future Pandemics 27/02/2022 Raisa Santos From increasing disease surveillance and developing a pan-coronavirus vaccine to ‘eco-health’ and public trust, participants in the COVID-19 Global Research and Innovation Forum considered ways to globally prepare for future pandemics and end the current one. The third such forum, hosted by the World Health Organization, brought together over 100 research scientists, experts, policy makers, […] Continue reading -> Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> One COVID Vaccine Jab After Recovery Cut Risk of Reinfection by Delta Variant Up to 82% 18/02/2022 Maayan Hoffman Individuals who recovered from COVID-19 and then received at least one shot of the Pfizer mRNA COVID-19 vaccine had a significantly lower risk of reinfection, according to a new study published Wednesday’s New England Journal of Medicine,. The study was conducted by researchers at Israel’s Clalit Health Services, in collaboration with Ben-Gurion University and Sapir […] Continue reading -> BA.2 Now Dominant in South Africa: Could New ‘Stealth’ Sub-Variant Delay Hoped-For Pandemic Reprieve? 11/02/2022 Maayan Hoffman The BA.2 sub-variant of Omicron is now the dominant COVID-19 variant in South Africa, the head of Africa’s Centers for Disease Control and Prevention (CDC) confirmed on Thursday – raising questions about whether the continued global creep of the new SARS-CoV2 sub-variant could dash hopes of a much-needed COVID-19 reprieve. “We have data from South […] Continue reading -> New Study Shows Correlation Between Vitamin D Deficiency and Severe COVID 07/02/2022 Maayan Hoffman Researchers make the argument for increasing vitamin D supplementation in low- and middle-income countries, where vaccines and other methods of COVID prevention may be less available. Maintaining adequate vitamin D levels could play a critical role in protecting against serious illness or death from COVID-19, according to new Israeli research. The study, published last week […] Continue reading -> In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> Posts navigation Older postsNewer posts
Expanding Global Research Capabilities to Prepare for Future Pandemics 27/02/2022 Raisa Santos From increasing disease surveillance and developing a pan-coronavirus vaccine to ‘eco-health’ and public trust, participants in the COVID-19 Global Research and Innovation Forum considered ways to globally prepare for future pandemics and end the current one. The third such forum, hosted by the World Health Organization, brought together over 100 research scientists, experts, policy makers, […] Continue reading -> Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> One COVID Vaccine Jab After Recovery Cut Risk of Reinfection by Delta Variant Up to 82% 18/02/2022 Maayan Hoffman Individuals who recovered from COVID-19 and then received at least one shot of the Pfizer mRNA COVID-19 vaccine had a significantly lower risk of reinfection, according to a new study published Wednesday’s New England Journal of Medicine,. The study was conducted by researchers at Israel’s Clalit Health Services, in collaboration with Ben-Gurion University and Sapir […] Continue reading -> BA.2 Now Dominant in South Africa: Could New ‘Stealth’ Sub-Variant Delay Hoped-For Pandemic Reprieve? 11/02/2022 Maayan Hoffman The BA.2 sub-variant of Omicron is now the dominant COVID-19 variant in South Africa, the head of Africa’s Centers for Disease Control and Prevention (CDC) confirmed on Thursday – raising questions about whether the continued global creep of the new SARS-CoV2 sub-variant could dash hopes of a much-needed COVID-19 reprieve. “We have data from South […] Continue reading -> New Study Shows Correlation Between Vitamin D Deficiency and Severe COVID 07/02/2022 Maayan Hoffman Researchers make the argument for increasing vitamin D supplementation in low- and middle-income countries, where vaccines and other methods of COVID prevention may be less available. Maintaining adequate vitamin D levels could play a critical role in protecting against serious illness or death from COVID-19, according to new Israeli research. The study, published last week […] Continue reading -> In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> Posts navigation Older postsNewer posts
Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> One COVID Vaccine Jab After Recovery Cut Risk of Reinfection by Delta Variant Up to 82% 18/02/2022 Maayan Hoffman Individuals who recovered from COVID-19 and then received at least one shot of the Pfizer mRNA COVID-19 vaccine had a significantly lower risk of reinfection, according to a new study published Wednesday’s New England Journal of Medicine,. The study was conducted by researchers at Israel’s Clalit Health Services, in collaboration with Ben-Gurion University and Sapir […] Continue reading -> BA.2 Now Dominant in South Africa: Could New ‘Stealth’ Sub-Variant Delay Hoped-For Pandemic Reprieve? 11/02/2022 Maayan Hoffman The BA.2 sub-variant of Omicron is now the dominant COVID-19 variant in South Africa, the head of Africa’s Centers for Disease Control and Prevention (CDC) confirmed on Thursday – raising questions about whether the continued global creep of the new SARS-CoV2 sub-variant could dash hopes of a much-needed COVID-19 reprieve. “We have data from South […] Continue reading -> New Study Shows Correlation Between Vitamin D Deficiency and Severe COVID 07/02/2022 Maayan Hoffman Researchers make the argument for increasing vitamin D supplementation in low- and middle-income countries, where vaccines and other methods of COVID prevention may be less available. Maintaining adequate vitamin D levels could play a critical role in protecting against serious illness or death from COVID-19, according to new Israeli research. The study, published last week […] Continue reading -> In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> Posts navigation Older postsNewer posts
One COVID Vaccine Jab After Recovery Cut Risk of Reinfection by Delta Variant Up to 82% 18/02/2022 Maayan Hoffman Individuals who recovered from COVID-19 and then received at least one shot of the Pfizer mRNA COVID-19 vaccine had a significantly lower risk of reinfection, according to a new study published Wednesday’s New England Journal of Medicine,. The study was conducted by researchers at Israel’s Clalit Health Services, in collaboration with Ben-Gurion University and Sapir […] Continue reading -> BA.2 Now Dominant in South Africa: Could New ‘Stealth’ Sub-Variant Delay Hoped-For Pandemic Reprieve? 11/02/2022 Maayan Hoffman The BA.2 sub-variant of Omicron is now the dominant COVID-19 variant in South Africa, the head of Africa’s Centers for Disease Control and Prevention (CDC) confirmed on Thursday – raising questions about whether the continued global creep of the new SARS-CoV2 sub-variant could dash hopes of a much-needed COVID-19 reprieve. “We have data from South […] Continue reading -> New Study Shows Correlation Between Vitamin D Deficiency and Severe COVID 07/02/2022 Maayan Hoffman Researchers make the argument for increasing vitamin D supplementation in low- and middle-income countries, where vaccines and other methods of COVID prevention may be less available. Maintaining adequate vitamin D levels could play a critical role in protecting against serious illness or death from COVID-19, according to new Israeli research. The study, published last week […] Continue reading -> In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> Posts navigation Older postsNewer posts
BA.2 Now Dominant in South Africa: Could New ‘Stealth’ Sub-Variant Delay Hoped-For Pandemic Reprieve? 11/02/2022 Maayan Hoffman The BA.2 sub-variant of Omicron is now the dominant COVID-19 variant in South Africa, the head of Africa’s Centers for Disease Control and Prevention (CDC) confirmed on Thursday – raising questions about whether the continued global creep of the new SARS-CoV2 sub-variant could dash hopes of a much-needed COVID-19 reprieve. “We have data from South […] Continue reading -> New Study Shows Correlation Between Vitamin D Deficiency and Severe COVID 07/02/2022 Maayan Hoffman Researchers make the argument for increasing vitamin D supplementation in low- and middle-income countries, where vaccines and other methods of COVID prevention may be less available. Maintaining adequate vitamin D levels could play a critical role in protecting against serious illness or death from COVID-19, according to new Israeli research. The study, published last week […] Continue reading -> In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> Posts navigation Older postsNewer posts
New Study Shows Correlation Between Vitamin D Deficiency and Severe COVID 07/02/2022 Maayan Hoffman Researchers make the argument for increasing vitamin D supplementation in low- and middle-income countries, where vaccines and other methods of COVID prevention may be less available. Maintaining adequate vitamin D levels could play a critical role in protecting against serious illness or death from COVID-19, according to new Israeli research. The study, published last week […] Continue reading -> In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> Posts navigation Older postsNewer posts
In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> Posts navigation Older postsNewer posts